STOCKWATCH
·
Pharmaceuticals
Business Update20 Mar 2025, 09:59 pm

Ajanta Pharma to Add State-of-the-art Liquid Formulation Facility at Pithampur Site

AI Summary

Ajanta Pharma Ltd is expanding its manufacturing capabilities by adding a new liquid formulation facility at its Pithampur site. The existing capacity is 6 million bottles per annum on a single shift basis, with a utilization of 175%. The proposed capacity addition is 12 million bottles per annum on a single shift basis. The investment required for this expansion is Rs. 92 cr, which will be financed through internal accruals. The rationale behind this move is to meet the growing demand for global markets. The capacity addition is expected to be completed by Q1 FY 2026.

Key Highlights

  • Ajanta Pharma to add a state-of-the-art liquid formulation facility at Pithampur site
  • Existing capacity is 6 million bottles per annum on a single shift basis with 175% utilization
  • Proposed capacity addition is 12 million bottles per annum on a single shift basis
  • Investment required is Rs. 92 cr, to be financed through internal accruals
  • Capacity addition aimed at meeting growing global demand for the Company's liquid formulations
AJANTPHARM
Pharmaceuticals
AJANTA PHARMA LTD.

Price Impact